O Estudo do Comportamento Verbal no Brasil

In the present study a historical review was realized of Brazilian master thesis and doctoral dissertations about verbal behavior, which were based on Skinner’ proposals (1957/1992) and carried out from 1968 to 2012. The following aspects were analyzed: a) type of work (thesis or dissertation, b) affiliation of the authors, c) advisor, d) line of research (basic, applied, conceptual or historical), e) methodology (descriptive or experimental), and f) research topics. In total, 177 thesis and 53 dissertations related to verbal behavior were identified. The results indicate that the study of verbal behavior in Brazil has been established as a research program and has grown over the years.O presente trabalho realizou uma revisão histórica de dissertações e teses brasileiras sobre comportamento verbal, com base na proposta de Skinner (1957), produzidas entre 1969 e 2012. Foram investigados: (a) número de dissertações e teses sobre o tema, (b) orientador, (c) tipo de pesquisa (descritiva ou experimental), (d) linha de pesquisa (básica, aplicada ou histórico-conceitual), (e) conceitos da análise do comportamento, (f) área de aplicação, (g) tema e (h) publicações decorrentes das dissertações e teses. Os resultados obtidos no presente trabalho permitem afirmar que o estudo do comportamento verbal, no Brasil, estabeleceu-se como programa de pesquisa e cresceu ao longo dos anos

Angiogenesis and chronic kidney disease

The number of patients requiring renal replacement therapy due to end-stage renal disease (ESRD) is increasing worldwide. The prevalence of chronic kidney disease (CKD), and the importance of CKD as a risk factor in development of ESRD and in complicating cardiovascular disease (CVD) have been confirmed. In recent years, the involvement of angiogenesis-related factors in the progression of CKD has been studied, and the potential therapeutic effects on CKD of modulating these factors have been identified. Vascular endothelial growth factor (VEGF)-A, a potent pro-angiogenic factor, is involved in the development of the kidney, in maintenance of the glomerular capillary structure and filtration barrier, and in the renal repair process after injury. VEGF-A is also involved in the development of early diabetic nephropathy, demonstrated by the therapeutic effects of anti-VEGF-A antibody. Angiopoietin (Ang)-1 induces the maturation of newly formed blood vessels, and the therapeutic effects of Ang-1 in diabetic nephropathy have been described. In experimental models of diabetic nephropathy, the therapeutic effects of angiogenesis inhibitors, including angiostatin, endostatin and tumstatin peptides, the isocoumarin NM-3, and vasohibin-1, have been reported

Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study

OBJECTIVE--To examine the relationships between microalbuminuria and the development of overt diabetic nephrology, elevated blood pressure, and a more atherogenic lipid profile; and to identify risk factors for the development of microalbuminuria in individuals with IDDM. Microalbuminuria has been associated with the subsequent development of overt diabetic nephropathy in individuals with IDDM. It is associated with elevated blood pressure and a more atherogenic lipid profile, but the temporal relationship between the development of microalbuminuria and the changes in these factors is unclear. RESEARCH DESIGN AND METHODS--Baseline characteristics were examined in 256 individuals with IDDM who had normal albumin excretion (urinary AER or = 2 timed urine collections) and were re-examined 2 yr later. RESULTS--At follow-up, 24 had developed microalbuminuria (AER 20-200 micrograms/min in > or = 2 timed urine collections) and 1 had developed overt nephropathy (AER > 200 micrograms/min). Overall, the significant independent predictors of microalbuminuria were HbA1 (P 20-yr duration. Low-density lipoprotein cholesterol was more important for subjects with shorter durations; whereas triglycerides were important for those with longer durations. CONCLUSIONS--These results suggest that glycemic control, age or duration of IDDM, disturbed lipids, and possibly elevated blood pressure all may contribute to the development of microalbuminuria; and, further, that the adverse cardiovascular risk profile seen in individuals with overt nephropathy may begin to develop even before the detection of microalbuminuria